Staccato® Granisetron Multiple Dose PK
Clinical trial NCT04327765 · COMPLETED
Trial details
- NCT number
- NCT04327765
- Sponsor
- Alexza Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-10
- Primary completion
- 2020-08-04
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.